TY  - JOUR
AU  - Bustos, Antonio
AU  - Selvi Sabater, Pablo
AU  - Benlloch, María
AU  - Drehmer, Eraci
AU  - López-Rodríguez, María Mar
AU  - Platero, Felix
AU  - Platero, Jose Luis
AU  - Escribá-Alepuz, Jesús
AU  - de la Rubia Ortí, Jose Enrique
PY  - 2021
DO  - 10.3390/medicina57020104
UR  - http://hdl.handle.net/10668/17050
T2  - Medicina (Kaunas, Lithuania)
AB  - Background and objectives: The aim of this study was to report a case of a patient with Charcot-Marie-Tooth disease type 2 (CMT2) treated with epigallocatechin gallate (EGCG) for 4 months in order to assess its therapeutic potential in CMT2. Materials...
LA  - en
KW  - Charcot-Marie-Tooth disease type 2
KW  - IL-6
KW  - epigallocatechin gallate
KW  - motor activity
KW  - paraoxonase 1
KW  - Aryldialkylphosphatase
KW  - Catechin
KW  - Charcot-Marie-Tooth Disease
KW  - Female
KW  - Hand Strength
KW  - Humans
KW  - Male
KW  - Walk Test
TI  - Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report.
TY  - research article
VL  - 57
ER  -